Novel coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Discharged patients with COVID-19; (2) Are male or female between the ages of 20 and 80; (3) Have post-COVID-19 symptoms include but not limited to breath difficulties, fatigue, sleep difficulties, anxiety or depression; (4) Have a stable condition and remain conscious and cooperative during trial; (5) Willing to join the trial and signed the informed consent form; (6) Promise not to participate in other forms of exercise.
Exclusion criteria
Exclusion criteria: (1) Patients with complications of underlying noncommunicable diseases such as chronic obstructive pulmonary disease, coronary heart disease, dementia, chronic kidney disease, immunosuppression and cancer; (2) Patients with mental illness; (3) Patients with cognitive dysfunction until unable to understand the whole trial process; (4) Patients with severe bone or joint diseases that affect movement (eg. spinal arthritis, severe osteoporosis, and periarthritis); (5) Patients with pregnancy or lactating; (6) Cigarettes Smokers; (7) Patients who participate in other form of exercise programs during trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Modified Medical Research Council (mMRC) dyspnoea scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fatigue Scale-14;PSQI;Patient Health Questionnaire-9 Scale;Respiratory Symptoms Scale;Modified Borg Scale; | — |
Countries
China